Associations of content and gene polymorphism of macrophage inhibitory factor-1 and chronic hepatitis C virus infection

Table 1 Comparison of baseline characteristics between chronic hepatitis C and groups

Parameter	Control group, n = 82	CHC group, n = 178	χ2 or Z	P value
Sex, M/F	47/35	99/79	χ2 = 0.066	0.798
Age in yr, ≤ 40/> 40	63/61	44/38	χ2 = 0.161	0.688
ALT in U/L, M/P5/P95	25.5/13.6/43.3	44.6/14.3/128.3	Z = -6.641	< 0.001
AST in U/L, M/P5/P95	21.6/11.3/35.8	41.4/19.3/115.2	Z = -8.925	< 0.001
TP in g/L, M/P5/P95	74.5/66.7/84.7	69.2/54.2/85.8	Z = -2.690	0.008
ALB in g/L, M/P5/P95	45.6/38.3/55.8	42.5/27.5/55.7	Z = -3.638	< 0.001
TBIL in mol/L, M/P5/P95	17.4/10.0/32.4	17.9/11.3/42.5	Z = -2.030	0.035
PIIINP in ng/mL, M/P5/P95	16.7/9.4/24.6	27.6/9.6/120.4	Z = -7.348	< 0.001
CIV in ng/mL, M/P5/P95	17.5/11.0/25.5	28.9/11.8/142.6	Z = -8.294	< 0.001
PLT as 109/L, M/P5/P95	204.0/121.5/286.4	177.0/56.0/289.0	Z = -2.780	0.003
MIC-1 in pg/mL, M/P5/P95	324.6/146.7/725.8	407.7/149.2/1535.5	Z = -3.072	0.001

ALB: Albumin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; CHC: Chronic hepatitis C; CIV: Type IV collagen; MIC-1: Macrophage inhibitory factor-1; PIIINP: Type III procollagen N-terminal peptide; PLT: Platelet; TBIL: Total bilirubin; TP: Total protein.